Search filters

Filters
Clear All

Phase

  • 9
  • 5
  • 4
  • 1
  • 5
  • 3
  • 11
  • 39
  • 7
  • 39

Found 39 Leukemia trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 100 years
All genders
Phase 1/2
Interventional
This study investigates the use of an investigational treatment, rapcabtagene autoleucel, for different types of blood cancers including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL), acute lymphoblastic leukemia (ALL), and high-risk large B-cell lymphoma (HR LBCL).The study consists of two phases. In Phase I, …
18 years - 120 years
Accepts healthy volunteer
All genders
This study investigates whether primary palliative care can serve as an alternative to specialty palliative care in improving the quality of life, symptoms, mood, coping, and end-of-life outcomes for patients with acute myeloid leukemia (AML). These patients face a sudden, life-threatening diagnosis requiring immediate hospitalization and treatment, which can cause …
99 years or below
All genders
The primary objective of this protocol is to collect and store peripheral blood samples from different acute and chronic, myeloid and lymphoid leukemias and non-leukemia cancer patients for research analysis. Freshly collected blood leukocytes will be separated from red blood cells on a ficoll gradient, counted, and stored in 5-10x10E6 …
18 years - 99 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication in patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML). The purpose of this study is to compare the investigational medication to another treatment in patients with CP-CML who have been previously treated with other medications.Participants in this study will be assigned …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the safety and effectiveness of an investigational medication in patients with advanced blood cancers, including Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia, and high-risk Myelodysplastic Syndrome.Participants in the study will receive the investigational medication either alone or in combination with other treatments. The study will monitor the …
99 years or below
All genders
The purpose of this study is understand changes in cognition, physical abilities, and quality of life of individuals receiving venetoclax-based chemotherapy.
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and feasibility of using T-cell receptor engineered donor T-cells in patients undergoing allogeneic peripheral blood stem cell transplantation. The study focuses on patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or acute lymphoblastic leukemia (ALL) who receive transplants from specific types of donors. The …
18 years or above
All genders
Phase 1
Interventional
This study investigates relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. It focuses on understanding the effects of an investigational medication called AUTX-703.The study evaluates the safety, tolerability, and how the body processes and responds to AUTX-703. It looks at how effective the investigational medication is in treating the conditions.Who can …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and effectiveness of combining two investigational medications, SNDX-5613 and gilteritinib, for treating relapsed or refractory acute myeloid leukemia (AML) with specific genetic mutations. This study focuses on patients whose leukemia has returned or not responded to treatment and who have mutations in the FLT3 gene, …
18 years or above
All genders
Phase 1
Interventional
This study investigates the use of CART123 cells in combination with ruxolitinib for patients with relapsed or refractory acute myeloid leukemia (AML). The purpose of this study is to assess the safety and early effectiveness of this combination treatment. Participants will receive a single infusion of CART123 cells after being …
11 - 20 of 39